MedTech Dive September 3, 2025
Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.
New data on heart devices, including updates on Johnson & Johnson’s Varipulse pulsed field ablation platform and Abbott’s Navitor transcatheter aortic valve implantation system, were among the medtech developments grabbing attention at the 2025 European Society of Cardiology Congress recently held in Madrid.
Here are three updates to know from the meeting:
J&J reports positive real-world Varipulse data
J&J said its Varipulse PFA platform demonstrated strong safety and effectiveness and procedural efficiency in a real-world analysis of 791 patients treated for the heart arrhythmia atrial fibrillation.
The VARIPURE post-market sub-study showed a 0.6% primary adverse event rate, with no strokes...
Today's Sponsors
Today's Sponsor